Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06748222 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

E-Mindfulness Approaches for Living After Breast Cancer

Study acronym: HEAL-ABC
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial sites expanded: 364 → 383 locationsv17
  2. Trial sites expanded: 334 → 364 locationsv16
  3. Trial sites expanded: 299 → 334 locationsv15
  4. Start date: Jun 12, 2025 to Jun 27, 2025v14
  5. Trial sites expanded: 277 → 299 locationsv13
Show 11 earlier versionsHide 11 earlier versions
  1. Study sites: 268 to 277v12
  2. Study sites: 242 to 268v11
  3. Study sites: 199 to 242v10
  4. Study sites: 187 to 199v9
  5. Phase: Not applicable to Phase 3v8
  6. Study sites: 139 to 187v7
  7. Study sites: 33 to 139v6
  8. Study sites: 1 to 33v5
  9. Re-verified, no change to tracked fieldsv4
  10. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Jun 1, 2025 to Jun 12, 2025v3 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 1, 2025 to Jun 12, 2025
  11. Primary endpoints: 1 to 2 Secondary endpoints: 2 to 4 · Study description revisedv2 Show 2 more changesShow less
    • Secondary endpoints: 2 to 4
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
NRG Oncology
67 trials monitored
See 5 trials at risk
Breast Cancer
5,213 trials monitored
See 271 trials at risk
Depression
2,998 trials monitored
See 166 trials at risk
NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.
Trial Details
NCT Number NCT06748222
Lead Sponsor NRG Oncology
Collaborators: National Cancer Institute (NCI)
Conditions Breast Cancer, Depression
Enrollment 402 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov